In 1976 an outbreak of severe respiratory illness occurred in some attendees of an American Legion Convention in Philadelphia, Pa. (2) . An estimated 180 persons were sick and 29 of them died (3) . The etiological agent has been shown to be a bacterium (3) , called the Legionnaires disease bacterium. There is now evidence that this organism was responsible for outbreaks of respiratory disease in the District of Columbia in 1965 (5) and in Pontiac, Mich., in 1968 (4) . A similar organism has been isolated from frozen material saved from the Pontiac outbreak and from the pleural fluid of a patient in Flint, Mich., who later died (5) . This is a report on the in vitro activity of 22 antimicrobial agents against Legionnaires disease bacterium.
MATERIALS AND METHODS Cultures. Six organisms were studied: four isolates were from the Philadelphia, Pa., outbreak of 1976; one isolate was recently obtained from pleural fluid of a patient who had died of pneumonia in Flint, Mich.; and one isolate was from the Pontiac, Mich., outbreak. The latter organism was grown from a lung nodule of a guinea pig that developed pneumonia during exposure in the Health Department building in Pontiac, Mich., in 1968. The lung nodule, frozen since 1968, was thawed and inoculated intraperitoneally into guinea pigs. Parts of spleens of guinea pigs were inoculated into yolk sacs of embryonated hen eggs. The bacterium was isolated from a yolk sac. These isolates were obtained from R. E. Weaver, Special Bacteriology Section, Center for Disease Control. The organisms were grown on Mueller-Hinton agar (BBL) supplemented with 1% IsoVitaleX (BBL) and 1% bovine hemoglobin (Difco) (MHIH agar Two studies on the in vitro activity of some antimicrobial agents on infection with the Legionnaires organism have been made. In one study, erythromycin was shown to be efficacious in curing guinea pigs infected with the organism; all infected guinea pigs that were not treated died (6) .
In the second study (V. J. Lewis and W. L. Thacker, personal communication), chicken embryos were protected from the infection when either rifampin, gentamicin, streptomycin, erythromycin, sulfadiazine, chloramphenicol, or cephalothin was given before the infecting dose of organisms. Rifampin and erythromycin also protected against embryo death if given at 72 h after the infecting dose, and the Recently, a patient with Legionnaires disease was initially treated unsuccessfully with cephalothin, but was cured when he was treated with erythromycin (500 mg, intravenously, every 6 h) and gentamicin (80 mg, intravenously, every 8 h). Within 24 h his temperature fell from 103°F (ca. 39.40C) to less than 100°F (ca. 37.8C), and then he had an uneventful recovery (7) .
All Although the MIC values for tetracycline were relatively high (4 to 8 ,ug/ml), minocycline and doxycycline were active (MIC, 0.25 to 1 ,ug/ml). Differences in the activities of these drugs for some groups of organisms have been previously reported, e.g., increased activity of minocycline on strains of Acinetobacter and Serratia (8) .
The only notable difference between the susceptibility data for these six isolates is that isolate 6 (the Pontiac strain) is more susceptible to the penicillins. Whether this was a factor in the absence of death among patients with "Pontiac fever" can only be a subject for conjecture. Even though these MIC values and other data suggest that erythromycin and possibly the aminoglycosides are efficacious agents in the treatment of patients with Legionnaires disease, the data are inadequate to recommend an optimal therapeutic regimen. Furthermore, therapy with appropriate drugs may fail even though the MICs are low, e.g., penicillin may not cure some patients with pneumonia caused by certain types of pneumococci, even though the organisms are quite susceptible (1) . Solely on the basis of these in vitro data, however, the best drugs for prospective clinical trials may be rifampin, cefoxitin, erythromycin, the aminoglycosides, chloramphenicol, minocycline, doxycycline, and sulfamethoxazole-trimethoprim. The penicillins and cephalosporins would probably require high dosages.
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